AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (369.3 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Original Article | Open Access

Effects of population aging on the mortality burden of related cancers in urban and rural areas of China, 2004-2017: a population-based study

Yali Chen,*Cuihong Yang,*Ning LiZixing WangPeng WuJin DuJingmei Jiang ( )
Department of Epidemiology and Biostatistics, Institute of Basic Medical Sciences, Chinese Academy of Medical Science/School of Basic Medicine, Peking Union Medical College, Beijing 100005, China

*These authors contributed equally to this work.

Show Author Information

Abstract

Objective

China is a developing country with urban-rural disparities and accelerating population aging. Therefore, quantifying the effects of population aging on the cancer mortality burden is urgently needed.

Methods

Using data from China’s death surveillance datasets (2004-2017), we decomposed and quantified the effects of population aging and factor variations on cancer mortality rates in urban and rural China during 2004-2017 through a decomposition method. R ratios were used to assess the extent of the mortality decreases attributable to factor variations offsetting the increases attributable to population aging for 4 aging-related cancers (lung, colorectal, esophageal, and stomach cancer).

Results

Overall, population aging has led to continued increases in cancer mortality rates in China during 2004-2017 (mortality rates attributable to population aging: 8.63/100,000 for urban men, 4.21/100,000 for urban women, 11.95/100,000 for rural men, and 5.66/100,000 for rural women). The 4 cancers displayed 3 patterns. The mortality rates from lung cancer in rural China and from colorectal cancer nationwide increased because of both population aging and factor variations. Population aging was primarily responsible for the growing mortality due to lung cancer in urban areas. However, for esophageal and stomach cancer, the effect of population aging was not dominant, thus resulting in decreases in mortality rates.

Conclusions

Health resource allocation should prioritize areas or cancers more adversely affected by population aging. The burden of cancer will continue to increase in the future, because of rapid population aging, but can still be offset or even reversed with enhanced cancer control and prevention.

Electronic Supplementary Material

Download File(s)
cbm-19-5-696-ESM.pdf (295.7 KB)

References

2

National Bureau of Statistics in China. China Statistic Yearboook, 2010. Beijing: China Statistics Press; 2010.

3

Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016; 66: 115-32.

4

Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021; 71: 7-33.

5
Cancer Research UK. Cancer mortality statistics. Update July 2021. Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/mortality#heading-Zero.
6

Wei W, Zeng H, Zheng R, Zhang S, An L, Chen R, et al. Cancer registration in China and its role in cancer prevention and control. Lancet Oncol. 2020; 21: e342-9.

7
United Nations. World Population Prospects 2019. Update July 2021. Available from: https://population.un.org/wpp/.
8

Laconi E, Marongiu F, DeGregori J. Cancer as a disease of old age: changing mutational and microenvironmental landscapes. Br J Cancer. 2020; 122: 943-52.

9

Moran A, Gu D, Zhao D, Coxson P, Wang YC, Chen C-S, et al. Future cardiovascular disease in China: markov model and risk factor scenario projections from the coronary heart disease policy model-China. Circ Cardiovasc Qual Outcomes. 2010; 3: 243-52.

10

Guzman Castillo M, Gillespie DOS, Allen K, Bandosz P, Schmid V, Capewell S, et al. Future declines of coronary heart disease mortality in England and Wales could counter the burden of population ageing. PLoS One. 2014; 9: e99482.

11

Pou SA, Tumas N, Coquet JB, Niclis C, Roman MD, Diaz MD. Burden of cancer mortality and differences attributable to demographic aging and risk factors in Argentina, 1986-2011. Cad Saude Publica. 2017; 33: e00016616.

12

Cheng X, Yang Y, Schwebel D, Liu Z, Li L, Cheng P, et al. Population ageing and mortality during 1990–2017: a global decomposition analysis. PLoS Med. 2020; 17: e1003138.

13

Li R, Cheng X, Schwebel D, Hu G. The impact of population aging on deaths in China, 1990–2017. Inj Prev. 2021; 27(Suppl 2): A23.

14

Wang X, Zheng A, He X, Jiang H. Integration of rural and urban healthcare insurance schemes in China: an empirical research. BMC Health Serv Res. 2014; 14: 142.

15

Zeng H, Zheng R, Guo Y, Zhang S, Zou X, Wang N, et al. Cancer survival in China, 2003–2005: a population-based study. Int J Cancer. 2015; 136: 1921-30.

16

Liu S, Wu X, Lopez AD, Wang L, Cai Y, Page A, et al. An integrated national mortality surveillance system for death registration and mortality surveillance, China. Bull World Health Organ. 2016; 94: 46-57.

17
World Health Organization. ICD-10 Version: 2010. Update July 2021, Available from: https://icd.who.int/browse10/2010/en#/.
19

Tsoi KKF, Hirai HW, Chan FCH, Griffiths S, Sung JJY. Cancer burden with ageing population in urban regions in China: projection on cancer registry data from World Health Organization. Br Med Bull. 2017; 121: 83-94.

20

Levin ML. The occurrence of lung cancer in man. Acta Unio Int Contra Cancrum. 1953; 9: 531-41.

21

Cheng X, Tan L, Gao Y, Yang Y, Schwebel DC, Hu G. A new method to attribute differences in total deaths between groups to population size, age structure and age-specific mortality rate. PLoS One. 2019; 14: e0216613.

22
Brignell J. Number talk: sorry, wrong number! The abuse of measurement. Brignell Associates; 2000: 102-3.
23

Sung H, Siegel RL, Rosenberg PS, Jemal A. Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry. Lancet Public Health. 2019; 4: e137-47.

24

Tapper EB, Parikh ND. Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study. Br Med J. 2018; 362: k2817.

25

Li J, Zhang B-N, Fan J-H, Pang Y, Zhang P, Wang S-L, et al. A Nation-Wide multicenter 10-year (1999-2008) retrospective clinical epidemiological study of female breast cancer in china. BMC Cancer. 2011; 11: 364.

26

Gabriel CA, Domchek SM. Breast cancer in young women. Breast Cancer Res. 2010; 12: 212.

30

Funatogawa I, Funatogawa T, Yano E. Trends in smoking and lung cancer mortality in Japan, by birth cohort, 1949-2010. Bull World Health Organ. 2013; 91: 332-40.

31
World Bank. Prevalence of current tobacco use (% of adults). Update July 2021. Available from: https://data.worldbank.org/indicator/SH.PRV.SMOK.
32

Yang G, Ma J, Chen A, Zhang Y, Samet JM, Taylor CE, et al. Smoking cessation in China: findings from the 1996 national prevalence survey. Tob Control. 2001; 10: 170.

33

Tomlinson R. China bans smoking on trains and buses. Br Med J. 1997; 314: 769.

34

Goodchild M, Zheng R. Tobacco control and Healthy China 2030. Tob Control. 2019; 28: 409.

35

Wang JB, Jiang Y, Liang H, Li P, Xiao HJ, Ji J, et al. Attributable causes of cancer in China. Ann Oncol. 2012; 23: 2983-9.

36

Wang T, Cai H, Sasazuki S, Tsugane S, Zheng W, Cho ER, et al. Fruit and vegetable consumption, Helicobacter pylori antibodies, and gastric cancer risk: a pooled analysis of prospective studies in China, Japan, and Korea. Int J Cancer. 2017; 140: 591-9.

37

Yang S, Lin S, Li N, Deng Y, Wang M, Xiang D, et al. Burden, trends, and risk factors of esophageal cancer in China from 1990 to 2017: an up-to-date overview and comparison with those in Japan and South Korea. J Hematol Oncol. 2020; 13: 146.

38

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68: 394-424.

41

Lin Y, Totsuka Y, Shan B, Wang C, Wei W, Qiao Y, et al. Esophageal cancer in high-risk areas of China: research progress and challenges. Ann Epidemiol. 2017; 27: 215-21.

42

Cheng H, Hu F, Zhang L, Yang G, Ma J, Hu J, et al. Prevalence of Helicobacter pylori infection and identification of risk factors in rural and urban Beijing, China. Helicobacter. 2009; 14: 128-33.

43

Wen D, Zou W, Wen X, Yang Y, Chen Y, He Y, et al. Urban–rural disparity in colorectal cancer incidence and increasing trend in relation to socioeconomic development and urbanization in China. J Int Med Res. 2018; 46: 4181-96.

44

Wen X, Wen D, Yang Y, Chen Y, Wang G, Shan B. Urbanrural disparity in Helicobacter pylori infection–related upper gastrointestinal cancer in China and the decreasing trend in parallel with socioeconomic development and urbanization in an endemic area. Ann Glob Health. 2017; 83: 444-62.

45

Feng R-M, Zong Y-N, Cao S-M, Xu R-H. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics? Cancer Commun. 2019; 39: 22.

46

Gersten O, Wilmoth JR. The cancer transition in Japan since 1951. Demogr Res. 2002; 7: 271-306.

47

Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the Human Development Index (2008–2030): a population-based study. Lancet Oncol. 2012; 13: 790-801.

48
American Cancer Society. Cancer Screening Guidelines Overview and Processes. Update July 2021. Available from: https://www.cancer.org/health-care-professionals/american-cancer-societyprevention-early-detection-guidelines/overview.html.
49

Zavoral M, Suchanek S, Zavada F, Dusek L, Muzik J, Seifert B, et al. Colorectal cancer screening in Europe. World J Gastroenterol. 2009; 15: 5907-15.

50
Global Health Data Exchange. GBD Results Tool. Update July 2021. Available from: http://ghdx.healthdata.org/gbd-results-tool.
51

Cao M, Li H, Sun D, He S, Yu Y, Li J, et al. Cancer screening in China: the current status, challenges, and suggestions. Cancer Lett. 2021; 506: 120-7.

52

Chen R, Liu Y, Song G, Li B, Zhao D, Hua Z, et al. Effectiveness of one-time endoscopic screening programme in prevention of upper gastrointestinal cancer in China: a multicentre population-based cohort study. Gut. 2021; 70: 251-60.

Cancer Biology & Medicine
Pages 696-706
Cite this article:
Chen Y, Yang C, Li N, et al. Effects of population aging on the mortality burden of related cancers in urban and rural areas of China, 2004-2017: a population-based study. Cancer Biology & Medicine, 2022, 19(5): 696-706. https://doi.org/10.20892/j.issn.2095-3941.2021.0538

125

Views

5

Downloads

7

Crossref

8

Web of Science

9

Scopus

Altmetrics

Received: 30 September 2021
Accepted: 24 December 2021
Published: 24 June 2022
©2022 Cancer Biology & Medicine.

Creative Commons Attribution-NonCommercial 4.0 International License

Return